about
3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer.Impact of radiotherapy in the management of locally advanced extrahepatic cholangiocarcinoma.Solitary fibrous tumor in the round ligament of the liver: a fortunate intraoperative discovery.Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients.Solid Pseudopapillary Tumor of the Pancreas: One Case with a Metastatic Evolution in a Caucasian Woman.Radiochemotherapy in the management of pancreatic cancer--part I: neoadjuvant treatment.A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment.Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer.Disease-free survival following resection in non-ductal periampullary cancers: A retrospective multicenter analysis.One case of intrahepatic cholangiocarcinoma amenable to resection after radioembolization.Genome profiling of pancreatic adenocarcinoma.Identification of genomic alterations associated with the aggressiveness of pancreatic cancer using an ultra-high-resolution CGH array.Predictive factors of severe complications for ampullary, bile duct and duodenal cancers following pancreaticoduodenectomy: Multivariate analysis of a 10-year multicentre retrospective series.Postoperative sepsis in cancer patients undergoing major elective digestive surgery is associated with increased long-term mortality.Long-term survivors after pancreatectomy for cancer: the TNM classification is outdated.A 25-gene classifier predicts overall survival in resectable pancreatic cancer.Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival.
P50
Q30234595-0F304212-5827-4B59-A31C-226773FE7B38Q31145431-4C92C702-6017-4D6D-B523-D070FAB6A9AFQ33401603-92995B39-887E-45A2-9EE6-79EEC715828FQ33989437-96CD5792-338D-475D-8C68-3F0260BF108FQ35980414-F6AAE9E1-8C3F-40AD-AE0B-9FEA39BF61FEQ36262290-78422D42-9B00-4578-B639-4160ED637802Q36267531-A91183C4-74CD-46DD-BA7D-AB58171AF85BQ36728796-D1070BC1-1220-4B37-9F37-3136700731E3Q37332554-F2AE7E14-BDBD-4CE0-8B5E-A221262F21EFQ38810413-23CCEC2D-4295-4F5A-8AE8-E3B85281EE2CQ39206964-F54FA973-B180-4375-8075-217824B1B6EEQ39574924-ACFF5D05-7A82-431F-B1CF-E55024CF1DF3Q39858190-48D4B7C5-3205-40DB-B21D-4B320FBAD026Q40164286-3D948825-FA99-4714-92DD-D08E0E6B58C5Q40935091-5CF12517-5047-411B-BB1A-21BC0AAB9E5CQ41431657-C8E71755-4B34-4203-B56E-C9A4CE7E5026Q41711884-3FC284A7-1588-47AD-8066-B1E768219AECQ41815041-2FEF1887-D291-44D4-9A04-F1FC5D227F81
P50
description
onderzoeker
@nl
name
Jean-Robert Delpero
@ast
Jean-Robert Delpero
@en
Jean-Robert Delpero
@es
Jean-Robert Delpero
@nl
Jean-Robert Delpero
@sl
type
label
Jean-Robert Delpero
@ast
Jean-Robert Delpero
@en
Jean-Robert Delpero
@es
Jean-Robert Delpero
@nl
Jean-Robert Delpero
@sl
prefLabel
Jean-Robert Delpero
@ast
Jean-Robert Delpero
@en
Jean-Robert Delpero
@es
Jean-Robert Delpero
@nl
Jean-Robert Delpero
@sl